Blog

All.Can Polska provides information related to the care of hemato-oncological patients in the time of the COVID-19 epidemic

All.Can Polska provides information related to the care of hemato-oncological patients in the time of the COVID-19 epidemic. Go to the website: https://hematoonkologia.pl/koronawirus

All.Can’s position on continued access to cancer care during the COVID 19 epidemic

The purpose of this document is to provide recommendations and practical tips to ensure effective care for cancer patients during the COVID-19 crisis. http://all-can.pl/data/stanowisko_All_Can_COVID_kwiecien_2020.pdf

XV Health Market Forum October 21st-22nd, 2019

The Health Market Forum was held for the 15th time. Representing  All.Can Poland Beata Ambroziewicz and Szymon Chrostowski participated as panelists in 2 sessions In the session “Financing health services…

All.Can Poland at the Cancer Prevention 2020 conference, September 2019

On September 18th, 2019, representatives of All.Can Poland participated in the Cancer Prevention 2020 conference organized by the Medical Research Agency. Conference participants discussed the directions outlined in the National…

Summer Oncology Academy for Journalists, August 2019

All.Can Poland took part in the IX Summer Academy of Oncology for the second time. The initiative was represented by Szymon Chrostowski, Chairman of the Steering Group of All.Can Poland,…

All.Can at the Congress of the Polish Society of Oncological Surgery, May 2019

All.Can Poland was invited to take part in the session “Cooperation of patients and oncologists during the XXV Jubilee Congress of the Polish Society of Oncological Surgery, which was held…

All.Can Polska at the IV Congress of Health Challenges, March 2019

On March 7th-8th, 2019, the IV Health Challenges Congress (HCC) took place. It is a forum for multi-threaded discussion on key issues for healthcare systems. Among the invited guests was…

XIV Health Market Forum, session “Indirect costs in the health care system” 23rd October 2018

The participants of the session discussed the definitions of indirect costs and the validity of the analysis of the so-called the total cost of disease, which is essential for a…